3628 results for «71»
3628 results
TAVI procedural complications - Part 4: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...
Debate: how will AI change the cardiology landscape in the next five years?
20 May 2026 – From EuroPCR 2026
Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...
Vascular access: femoral and radial
20 May 2026 – From EuroPCR 2026
This session explores vascular access techniques in interventional cardiology, emphasizing both femoral and radial approaches. It covers access-related bleeding and ischemic complications, safety and efficacy of distal radial programs, and innovations in sheath technology. Additional topics include post-procedural mobilization, management of radial artery recanalization, balloon fenestration...
Structural heart devices: what's new and how it reaches your cathlab
20 May 2026 – From EuroPCR 2026
Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...
AI fundamentals for busy cardiologists: opportunities, limitations and safe use
19 May 2026 – From EuroPCR 2026
Designed for busy cardiologists, this session elucidates the fundamentals of artificial intelligence relevant to cardiology practice. It covers the main AI tool families, including large language models and computer vision, and emphasizes effective and safe prompting techniques for clinical and academic use. Attendees will also learn...
When balloons fail: how to win against coronary calcium
19 May 2026 – From EuroPCR 2026
This session refines strategies to overcome undilatable calcified coronary lesions by integrating modern calcium-modification technologies into complex PCI workflows. Through multiple international case studies, it highlights approaches to achieve optimal stent expansion despite severe coronary calcium challenges.
Structural and valvular innovations
19 May 2026 – From EuroPCR 2026
This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...
STEMI 2026 - The precision revolution
19 May 2026 – From EuroPCR 2026
Explore the forefront of STEMI care with a focus on precision medicine, integrating artificial intelligence for pre-hospital triage, evidence-based complete revascularisation strategies, and advanced imaging guidance during primary PCI. This session also addresses tailored antithrombotic approaches, timing of mechanical support in cardiogenic shock, and management of...
Beyond the angiogram: contemporary management of STEMI
19 May 2026 – From EuroPCR 2026
This session provides an in-depth review of complex STEMI cases from diverse clinical settings, emphasizing optimisation of primary PCI strategies, complication management, and individualised antithrombotic therapy. Real-world cases from Albania, Macedonia, and Slovakia illustrate diagnostic challenges and therapeutic decision-making to improve patient outcomes.
Innovations in vascular therapies
19 May 2026 – From EuroPCR 2026
Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.
From diagnosis to device: decision-making and planning for mitral valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers a structured approach to mitral TEER, integrating advanced imaging techniques for detailed mitral valve morphology evaluation, procedural planning, and complication prediction. It highlights device selection considerations and emerging technologies to tailor interventions for complex mitral valve disease, supported by multiple case presentations and...
Healthcare professionals in the structural heart disease treatment
15 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the essential roles and contributions of various healthcare professionals involved in structural heart disease treatment. It offers insights into the unique responsibilities of medical technologists, nurses, and radiological technologists across preoperative, intraoperative, and postoperative stages, fostering collaboration and sharing practical tips to strengthen...
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.
Transcatheter electrosurgery and leaflet modification of the aortic valve
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...
TAVI: new evidence and clinical trials
14 Feb 2026 – From PCR Tokyo Valves 2026
This session reviews the latest evidence from head-to-head clinical trials comparing contemporary TAVI devices, including detailed discussions of the LANDMARK and COMPARE trials. It also highlights ongoing and upcoming clinical trials poised to influence guideline recommendations and expand the therapeutic scope of TAVI, providing crucial insights...
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the multidisciplinary team approach to managing structural heart disease, focusing on responses to unexpected intraoperative and postoperative situations. It features real-world experiences from a TAVI radiologic technologist, clinical engineer, TEER sonographer, and TEER nurse, emphasizing their respective roles in addressing intraoperative events, sudden...
Innovations in stentless coronary intervention: from DCB technologies to bioresorbable scaffolds
11 Dec 2025 – From GulfPCR-GIM 2025
This session delves into the evolving landscape of stentless coronary interventions, focusing on the structural diversity of Drug-Coated Balloons (DCB) and the promising future of bioresorbable scaffolds (BRS). It emphasizes the role of intracoronary imaging, particularly OCT, in optimizing these therapies. Attendees gain a comprehensive understanding...
NIRS-guided PCI: beyond calcium to precision PCI
11 Dec 2025 – From GulfPCR-GIM 2025
This session explores how near-infrared spectroscopy (NIRS) is redefining PCI by revealing what angiography cannot see. By identifying lipid-rich and vulnerable plaques, NIRS helps anticipate procedural risk and refine decision-making before stent implantation. The session shows how plaque composition, rather than calcium alone, can guide lesion...
Renal denervation today and tomorrow
11 Dec 2025 – From GulfPCR-GIM 2025
Renal denervation is re-emerging as a valuable therapeutic option for selected patients with hypertension.
This session explores how current evidence, consensus statements, and guidelines inform patient selection for ultrasound renal denervation, while providing practical insight into how the procedure is performed in daily practice.
Beyond the technical aspects,...
Challenging CTO Interventions - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session addresses the complexities of chronic total occlusion (CTO) interventions with a collection of challenging cases employing advanced techniques. Topics include IVUS-assisted recanalisation, hybrid approaches incorporating 3D wiring, retrograde interventions after antegrade failure, and management of procedural complications such as vessel rupture. The session also...
